Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
PLoS One
    January 2026
  1. MORISAKI M, Rezaali F, Lau LC, Boche D, et al
    Correction: Depression as a risk factor for Alzheimer's disease: A human post-mortem study.
    PLoS One. 2026;21:e0340296.
    >> Share

  2. ZAHEDIPOUR M, Saniee Abadeh M, Shojaei S
    Alzheimer's disease prediction via an explainable CNN using genetic algorithm and SHAP values.
    PLoS One. 2026;21:e0337800.
    >> Share

  3. HERNANDEZ NM, Silva-Perez M, Chin J
    Noradrenergic innervation across brain regions is altered by aging and by disease progression in a mouse model of Alzheimer's disease neuropathology.
    PLoS One. 2026;21:e0340611.
    >> Share

  4. LI R, Jiang S, Pi Z, Chen G, et al
    Early diagnosis of Alzheimer's Disease: Graph theoretical analysis of cerebellar network features based on 18F-AV45 PET.
    PLoS One. 2026;21:e0342738.
    >> Share

  5. EL FADILI M, Er-Rajy M, Mujwar S, Samadi A, et al
    Computational modeling for rational design of novel phenoxy tacrine derivatives targeting Alzheimer's disease.
    PLoS One. 2026;21:e0343723.
    >> Share

  6. AHMAD I, Waheed S, Alotaibi BS, Abbasi SW, et al
    Cheminformatics-driven discovery of natural isoquinoline alkaloid inhibitors of Beta-secretase I for Alzheimer's management.
    PLoS One. 2026;21:e0343717.
    >> Share

  7. HENAO ISAZA V, Aguillon D, Tobon-Quintero CA, Lopera F, et al
    Comprehensive methodology for sample enrichment in EEG biomarker studies for Alzheimer's risk classification.
    PLoS One. 2026;21:e0343722.
    >> Share

  8. MAO Z, Peng Y, Lin R, Guo X, et al
    Association of intraindividual differences in estimated glomerular filtration rates based on cystatin C and creatinine with dementia: A cohort study of the UK Biobank.
    PLoS One. 2026;21:e0344566.
    >> Share

  9. BRADY JJR, Bartlett L, Roccati E, Norris K, et al
    Psychosocial hierarchies of modifiable risk for Alzheimer's disease: A networks analysis.
    PLoS One. 2026;21:e0333148.
    >> Share

  10. SIAM MBH, Khan MR, Elahe MF, Arman MS, et al
    Effects of similarity networks in graph-based multi-omics classification.
    PLoS One. 2026;21:e0344754.
    >> Share

    January 2025
  11. EUESDEN J, Ali M, Robins C, Surendran P, et al
    Patient stratification by genetic risk in Alzheimer's disease is only effective in the presence of phenotypic heterogeneity.
    PLoS One. 2025;20:e0310977.
    >> Share

  12. LATHIKA RAJENDRAKUMAR A, Arbeev KG, Bagley O, Duan M, et al
    APOE4 and infectious diseases jointly contribute to brain glucose hypometabolism, a biomarker of Alzheimer's pathology: New findings from the ADNI.
    PLoS One. 2025;20:e0316808.
    >> Share

  13. RAO GA, Shoaibi A, Makadia R, Hardin J, et al
    CohortDiagnostics: Phenotype evaluation across a network of observational data sources using population-level characterization.
    PLoS One. 2025;20:e0310634.
    >> Share

  14. GUERGUER FZ, Bouribab A, Karim EM, Khedraoui M, et al
    Moroccan natural products for multitarget-based treatment of Alzheimer's disease: A computational study.
    PLoS One. 2025;20:e0313411.
    >> Share

  15. NERATTINI M, Williams S, Andy C, Carlton C, et al
    Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's disease.
    PLoS One. 2025;20:e0317303.
    >> Share

  16. WU Y, Cleverley K, Wiseman FK
    Reduction of Cystatin B results in increased cathepsin B activity in disomic but not Trisomy 21 human cellular and mouse models.
    PLoS One. 2025;20:e0316822.
    >> Share

  17. GUERGUER FZ, Rossafi B, Abchir O, Raouf YS, et al
    Potential Azo-8-hydroxyquinoline derivatives as multi-target lead candidates for Alzheimer's disease: An in-depth in silico study of monoamine oxidase and cholinesterase inhibitors.
    PLoS One. 2025;20:e0317261.
    >> Share

  18. LU H, Ni X, Man Chan SS, Cheng CPW, et al
    Pre-treatment subjective sleep quality as a predictive biomarker of tDCS effects in preclinical Alzheimer's disease patients: Secondary analysis of a randomised clinical trial.
    PLoS One. 2025;20:e0317700.
    >> Share

  19. LI X, Gong B, Chen X, Li H, et al
    Alzheimer's disease image classification based on enhanced residual attention network.
    PLoS One. 2025;20:e0317376.
    >> Share

  20. VITALI F, Wiegand JP, Parker-Halstead L, Tucker A, et al
    Weight trajectories in aging humanized APOE mice with translational validity to human Alzheimer's risk population: A retrospective analysis.
    PLoS One. 2025;20:e0314097.
    >> Share

  21. LIU N, Deng Q, Peng Z, Mao D, et al
    Characterization of gene expression profiles in Alzheimer's disease and osteoarthritis: A bioinformatics study.
    PLoS One. 2025;20:e0316708.
    >> Share

  22. WAN Z, Ma T
    The impact of apolipoprotein E, type ?4 allele on Alzheimer's disease pathological biomarkers: a comprehensive post-mortem pilot-analysis.
    PLoS One. 2025;20:e0303486.
    >> Share

  23. YAN H, Mubonanyikuzo V, Komolafe TE, Zhou L, et al
    Hybrid-RViT: Hybridizing ResNet-50 and Vision Transformer for Enhanced Alzheimer's disease detection.
    PLoS One. 2025;20:e0318998.
    >> Share

  24. NEAL SJ, Chitta S, Magden ER, Simmons JH, et al
    Characterizing plasma and cerebrospinal fluid biomarkers relevant to neurodegeneration in captive olive baboons (Papio anubis).
    PLoS One. 2025;20:e0318173.
    >> Share

  25. LI J, Tao L, Zhou Y, Zhu Y, et al
    Identification of biomarkers in Alzheimer's disease and COVID-19 by bioinformatics combining single-cell data analysis and machine learning algorithms.
    PLoS One. 2025;20:e0317915.
    >> Share


  26. Expression of Concern: Peptides of presenilin-1 bind the amyloid precursor protein ectodomain and offer a novel and specific therapeutic approach to reduce beta-amyloid in Alzheimer's disease.
    PLoS One. 2025;20:e0319769.
    >> Share

  27. MCCOOL S, Smith JC, Sladek A, Fan S, et al
    Retinal and thalamic alterations in the 5xFAD mouse model of Alzheimer's disease.
    PLoS One. 2025;20:e0319397.
    >> Share

  28. SU C, Zhang S, Zheng Q, Miao J, et al
    Prevalence and correlation of sarcopenia with Alzheimer's disease: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0318920.
    >> Share

  29. TAKOMTHONG P, Waiwut P, Yenjai C, Wangboonskul J, et al
    Kaempferia parviflora extract and its methoxyflavones as potential anti-Alzheimer assessing in vitro, integrated computational approach, and in vivo impact on behaviour in scopolamine-induced amnesic mice.
    PLoS One. 2025;20:e0316888.
    >> Share

  30. WANG Z, Li Z, Lin A, Zhang Q, et al
    Exploration of small molecules as inhibitors of potential BACE1 protein to treat amyloid cerebrovascular disease by employing molecular modeling and simulation approaches.
    PLoS One. 2025;20:e0317716.
    >> Share


  31. Retraction: Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.
    PLoS One. 2025;20:e0321152.
    >> Share

  32. HONDA K, Awazu A
    Potential multiple disease progression pathways in female patients with Alzheimer's disease inferred from transcriptome and epigenome data of the dorsolateral prefrontal cortex.
    PLoS One. 2025;20:e0313733.
    >> Share

  33. SILLAPAKONG P, Wakabayashi T, Suzuki K
    Naturido alleviates amyloid beta1-42-induced adverse effects in a transgenic Caenorhabditis elegans model of Alzheimer's disease.
    PLoS One. 2025;20:e0320636.
    >> Share

  34. MORISAKI M, Rezaali F, Lau LC, Boche D, et al
    Depression as a risk factor for Alzheimer's disease: A human post-mortem study.
    PLoS One. 2025;20:e0320561.
    >> Share

  35. ZSQA-UR-REHMAN, Awang MK, Rashid J, Ali G, et al
    Correction: Classification of Alzheimer disease using DenseNet-201 based on deep transfer learning technique.
    PLoS One. 2025;20:e0321795.
    >> Share

  36. MENG M, Shen X, Xie Y, Lan R, et al
    Insomnia and risk of all-cause dementia: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0318814.
    >> Share

  37. ALRUILY M, Abd El-Aziz AA, Mostafa AM, Ezz M, et al
    Ensemble deep learning for Alzheimer's disease diagnosis using MRI: Integrating features from VGG16, MobileNet, and InceptionResNetV2 models.
    PLoS One. 2025;20:e0318620.
    >> Share

  38. AMIN H, Bukhari SA, Chauhdary Z, Akhter N, et al
    Vigna radiata extracts in pumpkin and soya bean oil: A novel therapeutic approach for Alzheimer's disease.
    PLoS One. 2025;20:e0321183.
    >> Share

  39. JEMIMAH S, Abuhantash F, AlShehhi A
    c-Triadem: A constrained, explainable deep learning model to identify novel biomarkers in Alzheimer's disease.
    PLoS One. 2025;20:e0320360.
    >> Share

  40. LICHTY JD, Mane H, Yarmey VR, Miguel AS, et al
    Amyloid beta induces hormetic-like effects through major stress pathways in a C. elegans model of Alzheimer's Disease.
    PLoS One. 2025;20:e0315810.
    >> Share

  41. KAMIYA M, Osawa A, Otaka E, Kato K, et al
    Exploring emotion recognition in patients with mild cognitive impairment and Alzheimer's dementia undergoing a rehabilitation program emotion recognition in patients with dementia.
    PLoS One. 2025;20:e0322213.
    >> Share

  42. JOHNSON KJ, Johnson K, Grant A, Taglialatela G, et al
    Photobiomodulation therapy increases neural stem cell pool in aged 3xTg-AD mice.
    PLoS One. 2025;20:e0321668.
    >> Share

  43. TAO F, Deng S, Zhuo B, Liu J, et al
    Causal relationship between schizophrenia and five types of dementia: A bidirectional two-sample Mendelian randomization study.
    PLoS One. 2025;20:e0322752.
    >> Share


  44. Retraction: Structure-based virtual screening of Trachyspermum ammi metabolites targeting acetylcholinesterase for Alzheimer's disease treatment.
    PLoS One. 2025;20:e0324094.
    >> Share

  45. LIU S, Geng D
    A systematic analysis for disease burden, risk factors, and trend projection of Alzheimer's disease and other dementias in China and globally.
    PLoS One. 2025;20:e0322574.
    >> Share

  46. CATTO F, Kirschenbaum D, Economides AE, Reuss AM, et al
    Quantitative 3D histochemistry reveals region-specific amyloid-beta reduction by the antidiabetic drug netoglitazone.
    PLoS One. 2025;20:e0309489.
    >> Share

  47. BRUNO F, Aceto MA, Paparazzo E, Arcuri D, et al
    Genetic variability in ADAM17/TACE is associated with sporadic Alzheimer's disease risk, neuropsychiatric symptoms and cognitive performance on the Rey Auditory Verbal Learning and Clock Drawing Tests.
    PLoS One. 2025;20:e0309631.
    >> Share

  48. SADEGHI A, Noorbakhshnia M, Khodashenas S
    Protective potential of BM-MSC extracted Exosomes in a rat model of Alzheimer's disease.
    PLoS One. 2025;20:e0320883.
    >> Share

  49. KAYHAN KOCAK FO, Kumral E
    The relationship between dementia staging scales, cognitive-behavioral scales and functionality in patients with cognitive impairment.
    PLoS One. 2025;20:e0322572.
    >> Share

  50. GAO L, Hu S, Lv Y, Zheng G, et al
    Overexpression of LINC00672 promotes autophagy in Alzheimer's disease by upregulating GPNMB.
    PLoS One. 2025;20:e0322708.
    >> Share

  51. BAKER E, Leonenko G, Schmidt KM, Hill M, et al
    Correction: What does heritability of Alzheimer's disease represent?
    PLoS One. 2025;20:e0323769.
    >> Share

  52. JIANG H, Chen Z, Liu Y, Yang C, et al
    The structure of spontaneous speech changes in Alzheimer's disease: Crosslingual evidence from English and Greek.
    PLoS One. 2025;20:e0324270.
    >> Share

  53. KHEDRAOUI M, Karim EM, Abchir O, Errougui A, et al
    2D-QSAR-guided design of potent carbamate-based inhibitors of acetylcholinesterase.
    PLoS One. 2025;20:e0320789.
    >> Share

  54. HENNEY MA, Hansen BL, Hansen LS, Gronberg MG, et al
    Re-evaluating the choice of gamma stimulation frequency for the potential treatment of Alzheimer's disease: Novel invisible spectral flicker evokes gamma responses at various frequencies.
    PLoS One. 2025;20:e0321633.
    >> Share

  55. ZHOU Y, Yu G, Li H
    Hancinone possesses potentials on increasing the ability of HMC3 cells to phagocytosis of Abeta1-42 via TREM2/Syk/PI3K/AKT/mTOR signaling pathway.
    PLoS One. 2025;20:e0324202.
    >> Share

  56. ANZUM H, Sammo NS, Akhter S
    Leveraging transformers and explainable AI for Alzheimer's disease interpretability.
    PLoS One. 2025;20:e0322607.
    >> Share


  57. Retraction: Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer's Diseases.
    PLoS One. 2025;20:e0325958.
    >> Share

  58. LIU L, Li Y, Yang K
    Dynamically weighted graph neural network for detection of early mild cognitive impairment.
    PLoS One. 2025;20:e0323894.
    >> Share

  59. ELSHARKAWY AM, Hassanein F, Abouelkheir SS, Masoud IM, et al
    An experimental study of the dual modulation of the colchicine-induced rat model of Alzheimer's disease by superparamagnetic iron oxide nanoparticles (SPIONs) and the soluble product of Dipylidium caninum adult worm.
    PLoS One. 2025;20:e0324191.
    >> Share

  60. ARTEMAN KDS, da Rocha PDS, Leite DF, Oliveira AS, et al
    Plebeia catamarcensis and Tetragonisca fiebrigi (Hymenoptera, Apidae) propolis promotes longevity and anti-Alzheimer effects in Caenorhabditis elegans.
    PLoS One. 2025;20:e0321487.
    >> Share

  61. LI Z, Li Q, Li X, Luo W, et al
    AD-GCN: A novel graph convolutional network integrating multi-omics data for enhanced Alzheimer's disease diagnosis.
    PLoS One. 2025;20:e0325050.
    >> Share

  62. JIN Z, Liu N, Wei H
    Atherosclerosis is associated with amyloid and tau pathology via blood-brain barrier dysfunction in the hippocampus of aged human brains.
    PLoS One. 2025;20:e0324652.
    >> Share

  63. YANG X, Zhou J, Wang C, Li X, et al
    An ensemble-based 3D residual network for the classification of Alzheimer's disease.
    PLoS One. 2025;20:e0324520.
    >> Share

  64. MASUM MHU, Lokman SM, Parvin R, Rahman MS, et al
    Novel fungal metabolites as dual cholinesterase inhibitors: A computational approach for Alzheimer's disease therapy.
    PLoS One. 2025;20:e0326219.
    >> Share

  65. JOCK J, Beidelman ET, Phillips M, Kobayashi LC, et al
    Effects of pension eligibility expansion on men's memory decline and dementia probability: Findings from the HAALSI cohort in rural South Africa, 2014-2021.
    PLoS One. 2025;20:e0326321.
    >> Share

  66. SHAH M, Pervaiz S, Ahmad I, Ansari SH, et al
    Computer-aided discovery of dual-target compounds for Alzheimer's from ayurvedic medicinal plants.
    PLoS One. 2025;20:e0325441.
    >> Share

  67. WANG J, Yu ZW, Liu Q, Wu JX, et al
    Novel insights from comprehensive analysis: The role of cuproptosis and peripheral immune infiltration in Alzheimer's disease.
    PLoS One. 2025;20:e0325799.
    >> Share

  68. ZHANG J, Huang Y, Jiang Y, Li T, et al
    Knowledge and attitudes towards Alzheimer's disease among adult residents in Jiulongpo, Chongqing, China: A cross-sectional survey.
    PLoS One. 2025;20:e0327346.
    >> Share

  69. ELOVSSON G, Klingstedt T, Nilsson KPR, Brorsson AC, et al
    Diversity of Abeta aggregates produced in a gut-based Drosophila model of Alzheimer's disease.
    PLoS One. 2025;20:e0314832.
    >> Share

  70. GERARDS M, Baumeister A, Hubner C, Ribaldi F, et al
    Dementia risk estimation in persons at risk and the predictive turn in Alzheimer's disease-The PreTAD project: Study protocol with an ethical, clinical, linguistic, and legal approach.
    PLoS One. 2025;20:e0319868.
    >> Share

  71. VEGAS-GOMEZ L, Pizarro M, Garcia-Martin J, Arredondo-Alcala MA, et al
    Peripheral administration of blood from tau transgenic animals exacerbates brain tau-associated pathology.
    PLoS One. 2025;20:e0328470.
    >> Share

  72. JI H, Zhao Z, Zhao C
    Unveiling Aducanumab's safety profile: A comprehensive pharmacovigilance analysis.
    PLoS One. 2025;20:e0328076.
    >> Share

  73. LI Z, Prabhu SP, Popp ZT, Jain SS, et al
    A natural language processing approach to support biomedical data harmonization: Leveraging large language models.
    PLoS One. 2025;20:e0328262.
    >> Share

  74. JAMAL QMS, Alharbi AH, Ahmad V, Ahmad K, et al
    Integrated in silico identification of cholinesterase inhibitors from Nyctanthes arbor-tristis.
    PLoS One. 2025;20:e0328457.
    >> Share

  75. LI B, Golovynska I, Stepanov YV, Golovynskyi S, et al
    Transcranial photobiomodulation therapy with 808 nm light changes expression of genes and proteins associated with neuroprotection, neuroinflammation, oxidative stress, and Alzheimer's disease: Whole RNA sequencing of mouse cortex and hippocampus.
    PLoS One. 2025;20:e0326881.
    >> Share

  76. LIM S, Kim H, Lee Y
    Longitudinal tract-based spatial statistics analysis of white matter diffusivity changes and cognitive decline during the transition from MCI to Alzheimer's disease.
    PLoS One. 2025;20:e0329893.
    >> Share

  77. ZUSCHNEGG J, Ropele S, Opriessnig P, Schmidt R, et al
    The effect of tablet-based multimodal training on cognitive functioning in Alzheimer's disease: A randomized controlled trial.
    PLoS One. 2025;20:e0329931.
    >> Share

  78. BRIDGEFORD EW, Chung J, Anderson RJ, Mahzarnia A, et al
    Network biomarkers of Alzheimer's disease risk derived from joint volume and texture covariance patterns in mouse models.
    PLoS One. 2025;20:e0327118.
    >> Share

  79. CAMPBELL-COUSINS A, Guazzo F, Bastin ME, Parra MA, et al
    Multiplex nodal modularity: A novel network metric for the regional analysis of amnestic mild cognitive impairment during a working memory binding task.
    PLoS One. 2025;20:e0328736.
    >> Share

  80. SPENCER B, Marr RA, Gindi R, Potkar R, et al
    Correction: Peripheral Delivery of a CNS Targeted, Metalo-Protease Reduces Abeta Toxicity in a Mouse Model of Alzheimer's Disease.
    PLoS One. 2025;20:e0330647.
    >> Share

  81. ALMARRI B
    Deep learning-based Alzheimer's disease detection using magnetic resonance imaging and gene expression data.
    PLoS One. 2025;20:e0330085.
    >> Share

  82. GOODLAND MN, Banerjee S, Niehoff ML, Young BJ, et al
    Cannabidiol improves learning and memory deficits and alleviates anxiety in 12-month-old SAMP8 mice.
    PLoS One. 2025;20:e0296586.
    >> Share

  83. ZHANG Q, Deng Y, Xue M, Ni Z, et al
    Global trends in Alzheimer's disease and other dementias in adults aged 55 and above (1992-2021): An age-period-cohort analysis based on the GBD 2021.
    PLoS One. 2025;20:e0331204.
    >> Share

  84. FARHAN S, Haq YU, Khaliq MA, Afza S, et al
    Enhancing the early detection of Alzheimer's disease using an integrated CNN-LSTM framework: A robust approach for fMRI-based multi-stage classification.
    PLoS One. 2025;20:e0317968.
    >> Share

  85. MARIA, Khan A, Ajaj R, Rauf A, et al
    Secondary metabolites isolated from Fernandoa adenophylla (Wall. ex G.Don) steenis as multitarget inhibitors of cholinesterases for the treatment of Alzheimer's Disease, followed by molecular docking studies.
    PLoS One. 2025;20:e0331119.
    >> Share

  86. CAMPANELLI L, Sendoya JM, Brody S, Galeano P, et al
    New insights into the molecular biology of Alzheimer's-like cerebral amyloidosis achieved through multi-omics approaches.
    PLoS One. 2025;20:e0330859.
    >> Share

  87. HOSSAIN MM, Adhikari J, Dutta A, Khandaker A, et al
    Computational prediction of high-risk non-synonymous SNPs in human ApoE and their structural impact on amyloid-beta interaction in Alzheimer's disease pathogenesis.
    PLoS One. 2025;20:e0331339.
    >> Share

  88. QI W, Shi Y, Shen S, Wang B, et al
    Integration of wearable devices and artificial intelligence in Alzheimer's disease: A scoping review protocol.
    PLoS One. 2025;20:e0331129.
    >> Share

  89. WANG Z, Xiao S, Wan M
    Association of CSF visinin-like protein 1 levels with cerebral glucose metabolism among older adults.
    PLoS One. 2025;20:e0329386.
    >> Share

  90. PARK R, Chevalier C, Kieser S, Marizzoni M, et al
    Gut microbiome signatures in iNPH: Insights from a shotgun metagenomics study.
    PLoS One. 2025;20:e0330251.
    >> Share

  91. JEON S, Alia AO, Popovic J, Vassar R, et al
    ACE1 does not influence cerebral Abeta degradation or amyloid plaque accumulation in 5XFAD mice.
    PLoS One. 2025;20:e0330193.
    >> Share

  92. ISLAM M, Hasan MJ, Mahdy MRC
    CQ-CNN: A lightweight hybrid classical-quantum convolutional neural network for Alzheimer's disease detection using 3D structural brain MRI.
    PLoS One. 2025;20:e0331870.
    >> Share

  93. KOKORELIAS KM, Stall NM, Wasilewski M, Gignac MAM, et al
    Navigating the dementia caregiving journey: A scoping review protocol of interventions and their responsiveness to caregivers' evolving needs across the illness trajectory.
    PLoS One. 2025;20:e0333475.
    >> Share

  94. ZUBAIR M, Jaffar A, Hussain S, Akram S, et al
    Alzheimer's disease classification using a hybrid deep learning approach with multi-layer U-net segmentation and XAI driven analysis.
    PLoS One. 2025;20:e0332572.
    >> Share

  95. NOVOBILSKY R, Kusnierova P, Stepan D, Bartova P, et al
    Identification and evaluation of potential microRNA markers for diagnostics in neurodegenerative diseases and correlation with other biochemical markers.
    PLoS One. 2025;20:e0333801.
    >> Share

  96. TONG Q, Wu J, Jiao Q, Wu H, et al
    Global burden of Alzheimer's disease and other dementias attributable to smoking in 204 countries and territories, 1990-2021.
    PLoS One. 2025;20:e0334619.
    >> Share

  97. HODGSON NA, Talwar S, Aryal S, Finegan K, et al
    Beyond single support calls: Efficacy of follow-up callbacks for dementia caregivers using the Alzheimer's association helpline.
    PLoS One. 2025;20:e0333535.
    >> Share


  98. Editorial Note: Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor.
    PLoS One. 2025;20:e0335097.
    >> Share

  99. LIU Y, Wang J, Wu P, Tang F, et al
    Mitochondrial dysfunction-related metabolite methylmalonic acid is associated with decreased cognitive performance.
    PLoS One. 2025;20:e0332987.
    >> Share

  100. RONCERO C, Popov A, Seixas-Lima B, Lahiri D, et al
    Baseline task performance predicts mini-mental state examination improvement after individuals with dementia practice an N-back task with bilateral transcranial direct current stimulation.
    PLoS One. 2025;20:e0332372.
    >> Share

  101. KOJIMA N, Osuka Y, Sasai H, Shinkai S, et al
    Lower Firmicutes abundance in gut microbiota associated with amyloid-beta positivity in older adults in Japan as assessed by positron emission tomography.
    PLoS One. 2025;20:e0332801.
    >> Share

  102. HOSSAIN MR, Al Saber M, Hoque MA, Rahman MS, et al
    Green synthesis of silver nanoparticles from Brownlowia tersa leaf extract: multifaceted evaluation of antibacterial, antioxidant, cytotoxic, and anti-alzheimer potential.
    PLoS One. 2025;20:e0335524.
    >> Share

  103. YOO SS, Reddy A, Carroll W, Ploypradith K, et al
    Repeated application of transcranial ultrasound maintains spatial and recognition memory in 5xFAD mice with reduction of amyloid-beta burden.
    PLoS One. 2025;20:e0336114.
    >> Share

  104. CAMPANELLI L, Sendoya JM, Brody S, Galeano P, et al
    Correction: New insights into the molecular biology of Alzheimer's-like cerebral amyloidosis achieved through multi-omics approaches.
    PLoS One. 2025;20:e0336509.
    >> Share

  105. WARE EB, Zhu P, Noppert G, Fu M, et al
    Associations of perceived neighborhood factors and Alzheimer's disease polygenic score with cognition: Evidence from the Health and Retirement Study.
    PLoS One. 2025;20:e0336403.
    >> Share

  106. QIN R, Zhao H, Gao H, Liu H, et al
    Global trends in Alzheimer's disease and other dementias: A comprehensive analysis of incidence, socio-demographic variations, and future projections.
    PLoS One. 2025;20:e0338018.
    >> Share

  107. AHMED TF, Ahmed A, Haque Z, Azmi MB, et al
    Mapping the microRNA-mediated crosstalk between insulin resistance and Alzheimer's disease: A computational genomic insight.
    PLoS One. 2025;20:e0329056.
    >> Share


  108. Correction: Integration of wearable devices and artificial intelligence in Alzheimer's disease: A scoping review protocol.
    PLoS One. 2025;20:e0339031.
    >> Share

  109. ZHOU Y, Huang Y, Fan Y, Xue F, et al
    Co-regulation of microglial subgroups in Alzheimer's amyloid pathology: Implications for diagnosis and drug development.
    PLoS One. 2025;20:e0337741.
    >> Share

  110. HE Y, Yan Z, Liang Y, Yu Y, et al
    Abnormal brain network reconfiguration in neuropsychiatric disorders across cognitive decline, Depression, and Schizophrenia.
    PLoS One. 2025;20:e0337470.
    >> Share

  111. TANJIN R, Al-Amin M, Etee JM, Siddika A, et al
    An evaluation of Roluperidone as a promising repurposing candidate for Alzheimer's Disease: A Computational Investigation.
    PLoS One. 2025;20:e0338211.
    >> Share

  112. MISHIO BAWA E, Amoatika DA, Miller MC, Olatosi BA, et al
    Mapping the mortality-to-incidence ratios of Alzheimer's Disease and Related Dementias (ADRDs): Evidence from the South Carolina Alzheimer's disease registry.
    PLoS One. 2025;20:e0339785.
    >> Share

  113. TANG P, Chen X, Li P, Zhang L, et al
    Discovery of F-18 labeled repurposed CNS drugs by computational strategy for effective tau imaging and alzheimer's diagnosis.
    PLoS One. 2025;20:e0338901.
    >> Share

    January 2024
  114. PARKS ME
    Stochastic model of Alzheimer's disease progression using two-state Markov chains.
    PLoS One. 2024;19:e0295578.
    >> Share

  115. KONG F, Wu T, Dai J, Cai J, et al
    Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer's disease: A bibliometric analysis and visualization study from 2002 to 2022.
    PLoS One. 2024;19:e0295008.
    >> Share

  116. GAMMIE SC, Messing A, Hill MA, Kelm-Nelson CA, et al
    Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer's disease.
    PLoS One. 2024;19:e0291995.
    >> Share


  117. Editorial Note: Immunomodulation Targeting Abnormal Protein Conformation Reduces Pathology in a Mouse Model of Alzheimer's Disease.
    PLoS One. 2024;19:e0297928.
    >> Share

  118. NEUDORF B, Dinh C, Barnes V, Stergiou-Dayment C, et al
    Enhancing Minds in Motion(R) as a virtual program delivery model for people living with dementia and their care partners.
    PLoS One. 2024;19:e0291166.
    >> Share

  119. PAPAZOGLOU A, Henseler C, Weickhardt S, Teipelke J, et al
    Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer's disease mice.
    PLoS One. 2024;19:e0296959.
    >> Share

  120. BELLIO TA, Laguna-Torres JY, Campion MS, Chou J, et al
    Perinatal choline supplementation prevents learning and memory deficits and reduces brain amyloid Abeta42 deposition in AppNL-G-F Alzheimer's disease model mice.
    PLoS One. 2024;19:e0297289.
    >> Share

  121. SINGH S, Cocoros NM, Li X, Mazor KM, et al
    Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer's Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controll
    PLoS One. 2024;19:e0297562.
    >> Share

  122. KO YK, Kim E, Lee EJ, Nam SJ, et al
    Enrichment of infection-associated bacteria in the low biomass brain bacteriota of Alzheimer's disease patients.
    PLoS One. 2024;19:e0296307.
    >> Share

  123. LI YS, Xia YG, Liu YL, Jiang WR, et al
    Metabolic-dysfunction associated steatotic liver disease-related diseases, cognition and dementia: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0297883.
    >> Share

  124. SHAHID SS, Dzemidzic M, Butch ER, Jarvis EE, et al
    Estimating the synaptic density deficit in Alzheimer's disease using multi-contrast CEST imaging.
    PLoS One. 2024;19:e0299961.
    >> Share

  125. ABAYOMI SN, Sritharan P, Yan E, Saripella A, et al
    The diagnostic accuracy of the Mini-Cog screening tool for the detection of cognitive impairment-A systematic review and meta-analysis.
    PLoS One. 2024;19:e0298686.
    >> Share

  126. AHMADI M, Javaheri D, Khajavi M, Danesh K, et al
    A deeply supervised adaptable neural network for diagnosis and classification of Alzheimer's severity using multitask feature extraction.
    PLoS One. 2024;19:e0297996.
    >> Share

  127. ROYALL DR, Palmer RF
    INFLAMMATION's cognitive impact revealed by a novel "Line of Identity" approach.
    PLoS One. 2024;19:e0295386.
    >> Share

  128. YU F, Pituch KA, Maxfield M, Baena E, et al
    The associations between type 2 diabetes and plasma biomarkers of Alzheimer's disease in the Health and Aging Brain Study: Health Disparities (HABS-HD).
    PLoS One. 2024;19:e0295749.
    >> Share

  129. PEREIRA AAR, Pinto AM, Malerba HN, Toricelli M, et al
    Microdose lithium improves behavioral deficits and modulates molecular mechanisms of memory formation in female SAMP-8, a mouse model of accelerated aging.
    PLoS One. 2024;19:e0299534.
    >> Share

  130. AWARAYI NS, Twum F, Hayfron-Acquah JB, Owusu-Agyemang K, et al
    A bilateral filtering-based image enhancement for Alzheimer disease classification using CNN.
    PLoS One. 2024;19:e0302358.
    >> Share

  131. LEE C, Friedman A
    Generating PET scan patterns in Alzheimer's by a mathematical model.
    PLoS One. 2024;19:e0299637.
    >> Share

  132. LACEY C, Paterson T, Gawryluk JR
    Impact of APOE-epsilon alleles on brain structure and cognitive function in healthy older adults: A VBM and DTI replication study.
    PLoS One. 2024;19:e0292576.
    >> Share

  133. FUKUDA M, Okanishi H, Ino D, Ono K, et al
    Disturbance in the protein landscape of cochlear perilymph in an Alzheimer's disease mouse model.
    PLoS One. 2024;19:e0303375.
    >> Share

  134. NABAR NR, Yuan F, Lin X, Wang L, et al
    Correction: Cell Therapy: A Safe and Efficacious Therapeutic Treatment for Alzheimer's Disease in APP+PS1 Mice.
    PLoS One. 2024;19:e0303619.
    >> Share

  135. OTA A, Kitamura H, Sugimoto K, Ogawa M, et al
    Comparative studies of hair shaft components between healthy and diseased donors.
    PLoS One. 2024;19:e0301092.
    >> Share

  136. WOOLF B, Gill D, Grant AJ, Burgess S, et al
    MVMRmode: Introducing an R package for plurality valid estimators for multivariable Mendelian randomisation.
    PLoS One. 2024;19:e0291183.
    >> Share

  137. TAMADA Y, Kusama T, Ono S, Maeda M, et al
    Validity of claims-based definition of number of remaining teeth in Japan: Results from the Longevity Improvement and Fair Evidence Study.
    PLoS One. 2024;19:e0299849.
    >> Share

  138. ABUAWAD M, Rjoub A, Dumaidi Y, Daraghma M, et al
    Evaluation of knowledge and attitudes regarding Alzheimer's disease and related dementia among medical students in Palestine: A cross-sectional study.
    PLoS One. 2024;19:e0304012.
    >> Share

  139. BURKE JF, Copeland LL, Sussman JB, Hayward RA, et al
    Development and validation of the Michigan Chronic Disease Simulation Model (MICROSIM).
    PLoS One. 2024;19:e0300005.
    >> Share

  140. NADKARNI R, Han ZY, Anderson RJ, Allphin AJ, et al
    High-resolution hybrid micro-CT imaging pipeline for mouse brain region segmentation and volumetric morphometry.
    PLoS One. 2024;19:e0303288.
    >> Share

  141. SONG B, Yoshida S
    Explainability of three-dimensional convolutional neural networks for functional magnetic resonance imaging of Alzheimer's disease classification based on gradient-weighted class activation mapping.
    PLoS One. 2024;19:e0303278.
    >> Share

  142. RHODIUS-MEESTER HFM, van Maurik IS, Collij LE, van Gils AM, et al
    Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET.
    PLoS One. 2024;19:e0303111.
    >> Share

  143. HASSANZADEH R, Abrol A, Pearlson G, Turner JA, et al
    A confounder controlled machine learning approach: Group analysis and classification of schizophrenia and Alzheimer's disease using resting-state functional network connectivity.
    PLoS One. 2024;19:e0293053.
    >> Share

  144. AZIZAN Z, Zali H, Mirmotalebisohi SA, Bazrgar M, et al
    Deciphering molecular bridges: Unveiling the interplay between metabolic syndrome and Alzheimer's disease through a systems biology approach and drug repurposing.
    PLoS One. 2024;19:e0304410.
    >> Share

  145. FELDMAN HH, Luchsinger JA, Leger GC, Taylor C, et al
    Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam).
    PLoS One. 2024;19:e0302998.
    >> Share

  146. LOPES DA CUNHA P, Ruiz F, Ferrante F, Sterpin LF, et al
    Automated free speech analysis reveals distinct markers of Alzheimer's and frontotemporal dementia.
    PLoS One. 2024;19:e0304272.
    >> Share

  147. DENKINGER M, Baker S, Inglis B, Kobayashi S, et al
    Associations between regional blood-brain barrier permeability, aging, and Alzheimer's disease biomarkers in cognitively normal older adults.
    PLoS One. 2024;19:e0299764.
    >> Share

  148. AZMAL M, Hossen MS, Shohan MNH, Taqui R, et al
    A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: Molecular docking, ADME profiling and molecular dynamics simulations.
    PLoS One. 2024;19:e0304490.
    >> Share

  149. LIAO K, Lou Q
    Alzheimer's disease increases the risk of erectile dysfunction independent of cardiovascular diseases: A mendelian randomization study.
    PLoS One. 2024;19:e0303338.
    >> Share

  150. SANO M, Nishiura Y, Morikawa I, Hoshino A, et al
    Analysis of the alpha activity envelope in electroencephalography in relation to the ratio of excitatory to inhibitory neural activity.
    PLoS One. 2024;19:e0305082.
    >> Share

  151. MOHAMMADI A, Mohammadi M, Almasi-Dooghaee M, Mirmosayyeb O, et al
    Neutrophil to lymphocyte ratio in Alzheimer's disease: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0305322.
    >> Share

  152. HAQUE MA, Park IS
    An expeditious and facile method of amyloid beta (1-42) purification.
    PLoS One. 2024;19:e0307213.
    >> Share


  153. Retraction: Silencing GADD153/CHOP Gene Expression Protects against Alzheimer's Disease-Like Pathology Induced by 27-Hydroxycholesterol in Rabbit Hippocampus.
    PLoS One. 2024;19:e0307751.
    >> Share

  154. KELEMEN L, Gupta I, Yavarow Z, Smith SI, et al
    Clinician's perspectives on gene therapy for Alzheimer's disease: A qualitative study.
    PLoS One. 2024;19:e0307567.
    >> Share

  155. LUO S, Guo L, Chen N, Guo Q, et al
    CRY2 mediates the cognitive decline induced by sleep deprivation in 5xFAD mice.
    PLoS One. 2024;19:e0306930.
    >> Share

  156. AHMAD SR, Zeyaullah M, AlShahrani AM, Khan MS, et al
    Exploring the most promising anti - Depressant drug targeting Microtubule Affinity Receptor Kinase 4 involved in Alzheimer's Disease through molecular docking and molecular dynamics simulation.
    PLoS One. 2024;19:e0301179.
    >> Share

  157. RAJABLI F, Emekci A
    Addressing overlapping sample challenges in genome-wide association studies: Meta-reductive approach.
    PLoS One. 2024;19:e0296207.
    >> Share

  158. OSTERGAARD FG, Penninx BWJH, Das N, Arango C, et al
    The aperiodic exponent of neural activity varies with vigilance state in mice and men.
    PLoS One. 2024;19:e0301406.
    >> Share

  159. MEGHDADI AH, Salat D, Hamilton J, Hong Y, et al
    EEG and ERP biosignatures of mild cognitive impairment for longitudinal monitoring of early cognitive decline in Alzheimer's disease.
    PLoS One. 2024;19:e0308137.
    >> Share

  160. XIA C, Zhou M, Dong X, Zhao Y, et al
    Ginkgo biloba extract inhibits hippocampal neuronal injury caused by mitochondrial oxidative stress in a rat model of Alzheimer's disease.
    PLoS One. 2024;19:e0307735.
    >> Share

  161. WANG Y, Li M, Haughton D, Kazis LE, et al
    Transition of mild cognitive impairment to Alzheimer's disease: Medications as modifiable risk factors.
    PLoS One. 2024;19:e0306270.
    >> Share

  162. KAUFMANN L, Gruenbaum T, Janssen R, Weiss EM, et al
    Predictive value of somatic and functional variables for cognitive deterioration for early-stage patients with Alzheimer's Disease: Evidence from a prospective registry on dementia.
    PLoS One. 2024;19:e0307111.
    >> Share

  163. HORI A, Inaba H, Hato T, Tanaka K, et al
    Carvedilol suppresses ryanodine receptor-dependent Ca2+ bursts in human neurons bearing PSEN1 variants found in early onset Alzheimer's disease.
    PLoS One. 2024;19:e0291887.
    >> Share

  164. FUNG KW, Baye F, Baik SH, McDonald CJ, et al
    Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease and mortality: An observational cohort study of elderly Medicare enrollees.
    PLoS One. 2024;19:e0309222.
    >> Share

  165. HEGEDUS E, Pakaski M, Gosztolya G, Hoffmann I, et al
    Speech-related parameters are sensitive measures of acetylcholinesterase inhibitor therapy in mild Alzheimer's disease.
    PLoS One. 2024;19:e0308409.
    >> Share

  166. MEEHAN C, Lecocq S, Penner G
    A reproducible approach for the use of aptamer libraries for the identification of Aptamarkers for brain amyloid deposition based on plasma analysis.
    PLoS One. 2024;19:e0307678.
    >> Share

  167. ZIA-UR-REHMAN, Awang MK, Rashid J, Ali G, et al
    Classification of Alzheimer disease using DenseNet-201 based on deep transfer learning technique.
    PLoS One. 2024;19:e0304995.
    >> Share

  168. PARVAND M, Liang JJH, Bozorgmehr T, Born D, et al
    A familial Alzheimer's disease associated mutation in presenilin-1 mediates amyloid-beta independent cell specific neurodegeneration.
    PLoS One. 2024;19:e0289435.
    >> Share

  169. SHIN YB, Kim JH, Kwon MK, Myung JH, et al
    Optimized method development and validation for determining donepezil in rat plasma: A liquid-liquid extraction, LC-MS/MS, and design of experiments approach.
    PLoS One. 2024;19:e0309802.
    >> Share

  170. RAMIREZ J, Saleh IG, Yanagawa ESK, Shimogawa M, et al
    Multivalency drives interactions of alpha-synuclein fibrils with tau.
    PLoS One. 2024;19:e0309416.
    >> Share

  171. INAGAWA Y, Inagawa S, Takenoshita N, Yamamoto R, et al
    Utility of neuromelanin-sensitive MRI in the diagnosis of dementia with Lewy bodies.
    PLoS One. 2024;19:e0309885.
    >> Share

  172. STELLICK BEDREJO CA, Greenshaw A, Paulden M, Yap S, et al
    Do beta-amyloid-targeted interventions improve cognition, physical functioning, and overt behaviour of Alzheimer's Disease (AD) patients: Protocol for meta-analysis of Phase 3 clinical trials both completed and terminated.
    PLoS One. 2024;19:e0307761.
    >> Share

  173. NEELOTPOL S, Rezwan R, Singh T, Mayesha II, et al
    Pharmacological intervention of behavioural traits and brain histopathology of prenatal valproic acid-induced mouse model of autism.
    PLoS One. 2024;19:e0308632.
    >> Share

  174. YANG X, Hong K, Zhang D, Wang K, et al
    Early diagnosis of Alzheimer's Disease based on multi-attention mechanism.
    PLoS One. 2024;19:e0310966.
    >> Share

  175. KRYUKOVA OV, Korostin DO, Belova VA, Cheranev VV, et al
    Effect of ACE mutations on blood ACE phenotype parameters.
    PLoS One. 2024;19:e0308289.
    >> Share

  176. LEE M, Ahn KS, Kim M
    Effects of Artemisia asiatica ex on Akkermansia muciniphila dominance for modulation of Alzheimer's disease in mice.
    PLoS One. 2024;19:e0312670.
    >> Share

  177. ASHRAF T, Idrees N, Belay MB
    Regression analysis of topological indices for predicting efficacy of Alzheimer's drugs.
    PLoS One. 2024;19:e0309477.
    >> Share

  178. YOON G, Kam MK, Koh YH, Jo C, et al
    Palmitoyl-L-carnitine induces tau phosphorylation and mitochondrial dysfunction in neuronal cells.
    PLoS One. 2024;19:e0313507.
    >> Share

  179. ZHANG XY, Zhang H, Bao QN, Yin ZH, et al
    Diagnostic value of arterial spin labeling for Alzheimer's disease: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0311016.
    >> Share

  180. SHEN H, Nie J, Li G, Tian H, et al
    Stem cell factor restrains endoplasmic reticulum stress-associated apoptosis through c-Kit receptor activation of JAK2/STAT3 axis in hippocampal neuronal cells.
    PLoS One. 2024;19:e0310872.
    >> Share

  181. HE R, Zhang Q, Wang L, Hu Y, et al
    Exploring the feasibility of using mice as a substitute model for investigating microglia in aging and Alzheimer's disease though single cell analysis.
    PLoS One. 2024;19:e0311374.
    >> Share

  182. MAFI JN, Walling AM, Villaflores C, Vangala S, et al
    Correction: A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer's and related
    PLoS One. 2024;19:e0315516.
    >> Share

  183. ZHOU X, Kedia S, Meng R, Gerstein M, et al
    Deep learning analysis of fMRI data for predicting Alzheimer's Disease: A focus on convolutional neural networks and model interpretability.
    PLoS One. 2024;19:e0312848.
    >> Share

  184. ALROUJI M, Yasmin S, Alshammari MS, Alhumaydhi FA, et al
    Unveiling Cathepsin B inhibition with repurposed drugs for anticancer and anti-Alzheimer's drug discovery.
    PLoS One. 2024;19:e0316010.
    >> Share

  185. MUSA MS, Islam MT, Billah W, Hossain MS, et al
    Structure-based virtual screening of Trachyspermum ammi metabolites targeting acetylcholinesterase for Alzheimer's disease treatment.
    PLoS One. 2024;19:e0311401.
    >> Share

  186. SAEED A, Waris A, Fuwad A, Iqbal J, et al
    Random survival forest model for early prediction of Alzheimer's disease conversion in early and late Mild cognitive impairment stages.
    PLoS One. 2024;19:e0314725.
    >> Share

  187. YANG X, Fan Z, Li Z, Zhou J, et al
    Resting-state EEG microstate features for Alzheimer's disease classification.
    PLoS One. 2024;19:e0311958.
    >> Share

  188. SHIM SR, Kim JY, Kwon KY, Shin J, et al
    Effects of rivastigmine on gait in patients with neurodegenerative disorders: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0310900.
    >> Share

  189. SHINOMOTO M, Takeuchi C, Tatebe H, Kitani-Morii F, et al
    Comparison between DSQIID total / sub-item scores and plasma p-tau elevation in adults with Down's syndrome.
    PLoS One. 2024;19:e0311878.
    >> Share

  190. LEE GB, Jeong YJ, Kang DY, Yun HJ, et al
    Multimodal feature fusion-based graph convolutional networks for Alzheimer's disease stage classification using F-18 florbetaben brain PET images and clinical indicators.
    PLoS One. 2024;19:e0315809.
    >> Share

  191. GOLROKHIAN-SANI AA, Morcos M, Philippi A, Al-Rawi R, et al
    Temporal trends in mental health terminology in Alzheimer's disease clinical trials.
    PLoS One. 2024;19:e0310264.
    >> Share

    January 2023
  192. TIAN Y, Kuruvilla MV, Park M
    The use of virtual reality in screening for preclinical Alzheimer's disease: A scoping review protocol.
    PLoS One. 2023;18:e0282436.
    >> Share

  193. GARCIA MANRIQUEZ BA, Papapanagiotou JA, Strysick CA, Green EH, et al
    Nanoparticulate air pollution disrupts proteostasis in Caenorhabditis elegans.
    PLoS One. 2023;18:e0275137.
    >> Share

  194. KARAMACOSKA D, Chan DKY, Leung I, Liu JX, et al
    Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer's disease with cerebrovascular disease.
    PLoS One. 2023;18:e0265285.
    >> Share

  195. SHOBEIRI P, Alilou S, Jaberinezhad M, Zare F, et al
    Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis.
    PLoS One. 2023;18:e0281784.
    >> Share

  196. LI Y, Liu H, Li R
    Study of Bayesian variable selection method on mixed linear regression models.
    PLoS One. 2023;18:e0283100.
    >> Share

  197. LEE LH, Wu SC, Ho CF, Liang WL, et al
    White matter hyperintensities in cholinergic pathways may predict poorer responsiveness to acetylcholinesterase inhibitor treatment for Alzheimer's disease.
    PLoS One. 2023;18:e0283790.
    >> Share

  198. MRAZ H, Tong CY, Liu KPY
    Semantic-based memory-encoding strategy and cognitive stimulation in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised cluster controlled trial.
    PLoS One. 2023;18:e0283449.
    >> Share

  199. AMORIM IS, Challal S, Cistarelli L, Dorval T, et al
    A seeding-based neuronal model of tau aggregation for use in drug discovery.
    PLoS One. 2023;18:e0283941.
    >> Share

  200. FAISAL M, Aid J, Nodirov B, Lee B, et al
    Preclinical trials in Alzheimer's disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice.
    PLoS One. 2023;18:e0281003.
    >> Share

  201. BAKER E, Leonenko G, Schmidt KM, Hill M, et al
    What does heritability of Alzheimer's disease represent?
    PLoS One. 2023;18:e0281440.
    >> Share

  202. GIRGIN M, Isik S, Kantarci-Carsibasi N
    Proposing novel natural compounds against Alzheimer's disease targeting acetylcholinesterase.
    PLoS One. 2023;18:e0284994.
    >> Share

  203. BAUZA M, Krstulovic M, Krupic J
    Unsupervised, frequent and remote: A novel platform for personalised digital phenotyping of long-term memory in humans.
    PLoS One. 2023;18:e0284220.
    >> Share

  204. ALATRANY AS, Khan W, Hussain A, Al-Jumeily D, et al
    Wide and deep learning based approaches for classification of Alzheimer's disease using genome-wide association studies.
    PLoS One. 2023;18:e0283712.
    >> Share

  205. SHEPHERD-BANIGAN M, Miller KEM, Hastings SN, Schleiden LJ, et al
    Use of high cost care among Veterans with comorbid mental illness and Alzheimer's Disease and related dementias.
    PLoS One. 2023;18:e0282071.
    >> Share

  206. MURPHY C, Dyer AH, Lawlor B, Kennelly SP, et al
    What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?
    PLoS One. 2023;18:e0285529.
    >> Share

  207. GATTO RG, Carlos AF, Reichard RR, Lowe VJ, et al
    Comparative assessment of regional tau distribution by Tau-PET and Post-mortem neuropathology in a representative set of Alzheimer's & frontotemporal lobar degeneration patients.
    PLoS One. 2023;18:e0284182.
    >> Share

  208. FARINA MP, Saenz J, Crimmins EM
    Does adding MRI and CSF-based biomarkers improve cognitive status classification based on cognitive performance questionnaires?
    PLoS One. 2023;18:e0285220.
    >> Share

  209. TAULE T, Eide IS, Fjaer L, Myrberget MA, et al
    Norwegian version of the Edinburgh cognitive and behavioural ALS screen: Construct validity, internal consistency, inter-rater, and test-retest reliability.
    PLoS One. 2023;18:e0285307.
    >> Share

  210. JEMIMAH S, Chabib CMM, Hadjileontiadis L, AlShehhi A, et al
    Gut microbiome dysbiosis in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0285346.
    >> Share

  211. SU Y, Wang D, Liu N, Yang J, et al
    Clostridium butyricum improves cognitive dysfunction in ICV-STZ-induced Alzheimer's disease mice via suppressing TLR4 signaling pathway through the gut-brain axis.
    PLoS One. 2023;18:e0286086.
    >> Share

  212. BRAUN DJ, Frazier HN, Davis VA, Coleman MJ, et al
    Early chronic suppression of microglial p38alpha in a model of Alzheimer's disease does not significantly alter amyloid-associated neuropathology.
    PLoS One. 2023;18:e0286495.
    >> Share

  213. RADWAN AA, Alanazi FK, Raish M
    Design and synthesis of multi-functional small-molecule based inhibitors of amyloid-beta aggregation: Molecular modeling and in vitro evaluation.
    PLoS One. 2023;18:e0286195.
    >> Share

  214. JEONG WC, Min JY, Kang TG, Bae H, et al
    Association between pseudoexfoliation and Alzheimer's disease-related brain atrophy.
    PLoS One. 2023;18:e0286727.
    >> Share

  215. TSIANOU CC, Kvetina J, Radochova V, Kohoutova D, et al
    The effect of single and repeated doses of rivastigmine on gastric myoelectric activity in experimental pigs.
    PLoS One. 2023;18:e0286386.
    >> Share

  216. HANTKE NC, Kaye J, Mattek N, Wu CY, et al
    Correlating continuously captured home-based digital biomarkers of daily function with postmortem neurodegenerative neuropathology.
    PLoS One. 2023;18:e0286812.
    >> Share

  217. WU S, Stogios N, Hahn M, Navagnanavel J, et al
    Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0286887.
    >> Share

  218. MUURLING M, Pasmooij AMG, Koychev I, Roik D, et al
    Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.
    PLoS One. 2023;18:e0285807.
    >> Share

  219. KHAYER N, Motamed N, Marashi SA, Goshadrou F, et al
    RT-DOb, a switch gene for the gene pair Csf1r, Milr1, can influence the onset of Alzheimer's disease by regulating communication between mast cell and microglia.
    PLoS One. 2023;18:e0288134.
    >> Share

  220. MEKLI K, Lophatananon A, Maharani A, Nazroo JY, et al
    Association between an inflammatory biomarker score and future dementia diagnosis in the population-based UK Biobank cohort of 500,000 people.
    PLoS One. 2023;18:e0288045.
    >> Share

  221. THAMMASART S, Namchaiw P, Pasuwat K, Tonsomboon K, et al
    Attenuation Abeta1-42-induced neurotoxicity in neuronal cell by 660nm and 810nm LED light irradiation.
    PLoS One. 2023;18:e0283976.
    >> Share

  222. WILLIAMS E, Theys C, McAuliffe M
    Lexical-semantic properties of verbs and nouns used in conversation by people with Alzheimer's disease.
    PLoS One. 2023;18:e0288556.
    >> Share

  223. SUN Z, Zhang Y, Zhang M, Zhou S, et al
    Integrated brain and plasma dual-channel metabolomics to explore the treatment effects of Alpinia oxyphyllaFructus on Alzheimer's disease.
    PLoS One. 2023;18:e0285401.
    >> Share

  224. NI P, Pan K, Zhao B
    Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease.
    PLoS One. 2023;18:e0289068.
    >> Share

  225. LU H, Li J, Yang NS, Lam LCW, et al
    Using gamma-band transcranial alternating current stimulation (tACS) to improve sleep quality and cognition in patients with mild neurocognitive disorders due to Alzheimer's disease: A study protocol for a randomized controlled trial.
    PLoS One. 2023;18:e0289591.
    >> Share

  226. MONIN JK, McAvay G, Zang E, Vander Wyk B, et al
    Associations between dementia staging, neuropsychiatric behavioral symptoms, and divorce or separation in late life: A case control study.
    PLoS One. 2023;18:e0289311.
    >> Share

  227. YOON JA, Kong IJ, Choi I, Cha J, et al
    Correlation between cerebral hemodynamic functional near-infrared spectroscopy and positron emission tomography for assessing mild cognitive impairment and Alzheimer's disease: An exploratory study.
    PLoS One. 2023;18:e0285013.
    >> Share

  228. BASTOS M, da Silva MP, da Silva D, Negrao GN, et al
    Factors associated with Alzheimer's disease prevalence and mortality in Brazil-An ecological study.
    PLoS One. 2023;18:e0283936.
    >> Share

  229. ROVANG MS, Selnes P, MacIntosh BJ, Rasmus Groote I, et al
    Segmenting white matter hyperintensities on isotropic three-dimensional Fluid Attenuated Inversion Recovery magnetic resonance images: Assessing deep learning tools on a Norwegian imaging database.
    PLoS One. 2023;18:e0285683.
    >> Share

  230. YAGHMAEI E, Pierce A, Lu H, Patel YM, et al
    A causal inference study: The impact of the combined administration of Donepezil and Memantine on decreasing hospital and emergency department visits of Alzheimer's disease patients.
    PLoS One. 2023;18:e0291362.
    >> Share

  231. STOLZENBURG LR, Esmaeeli S, Kulkarni AS, Murphy E, et al
    Functional characterization of a single nucleotide polymorphism associated with Alzheimer's disease in a hiPSC-based neuron model.
    PLoS One. 2023;18:e0291029.
    >> Share

  232. NGUYEN TTT, Lee HH, Huang LK, Hu CJ, et al
    Heterogeneity of Alzheimer's disease identified by neuropsychological test profiling.
    PLoS One. 2023;18:e0292527.
    >> Share

  233. ZHANG GH, Chin KL, Yan SY, Pare R, et al
    Antioxioxidant and antiapoptotic effects of Thymosin beta4 in Abeta-induced SH-SY5Y cells via the 5-HTR1A/ERK axis.
    PLoS One. 2023;18:e0287817.
    >> Share

  234. HENRY DS, Pellegrino RG
    A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer's disease and related dementias among male and female patients aged 65 years and older supporting the need for a phase III clinical trial.
    PLoS One. 2023;18:e0292863.
    >> Share

  235. ZHOU Q, Yang D, Xiong C, Li X, et al
    Atopic dermatitis and cognitive dysfunction in middle-aged and older adults: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0292987.
    >> Share

  236. BOYANOVA ST, Lloyd-Morris E, Corpe C, Rahman KM, et al
    Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer's disease.
    PLoS One. 2023;18:e0286278.
    >> Share

  237. KOYCHEV I, Marinov E, Young S, Lazarova S, et al
    Identification of preclinical dementia according to ATN classification for stratified trial recruitment: A machine learning approach.
    PLoS One. 2023;18:e0288039.
    >> Share

  238. ISMAIL H, Khalid D, Waseem D, Ijaz MU, et al
    Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer's disease combined with insilico molecular docking.
    PLoS One. 2023;18:e0286349.
    >> Share

  239. BESSER LM, Chrisphonte S, Kleiman MJ, O'Shea D, et al
    The Healthy Brain Initiative (HBI): A prospective cohort study protocol.
    PLoS One. 2023;18:e0293634.
    >> Share

  240. LI F, Chen H, Mao N, Liu H, et al
    Dietary fiber intake and cognitive impairment in older patients with chronic kidney disease in the United States: A cross-sectional study.
    PLoS One. 2023;18:e0291690.
    >> Share

  241. MCCANN E, Lee S, Coleman F, O'Sullivan JD, et al
    Pareidolias are a function of visuoperceptual impairment.
    PLoS One. 2023;18:e0293942.
    >> Share

  242. PURRO SA, Farmer M, Noble E, Sarell CJ, et al
    Two mouse models of Alzheimer's disease accumulate amyloid at different rates and have distinct Abeta oligomer profiles unaltered by ablation of cellular prion protein.
    PLoS One. 2023;18:e0294465.
    >> Share

  243. JAHAN S, Abu Taher K, Kaiser MS, Mahmud M, et al
    Explainable AI-based Alzheimer's prediction and management using multimodal data.
    PLoS One. 2023;18:e0294253.
    >> Share

  244. ZOU T, Zhou X, Wang Q, Zhao Y, et al
    Associations of serum DNA methylation levels of chemokine signaling pathway genes with mild cognitive impairment (MCI) and Alzheimer's disease (AD).
    PLoS One. 2023;18:e0295320.
    >> Share

  245. WU X, Cao S, Zou Y, Wu F, et al
    Traditional Chinese Medicine studies for Alzheimer's disease via network pharmacology based on entropy and random walk.
    PLoS One. 2023;18:e0294772.
    >> Share

  246. ZANG L, Liu X, Li Y, Liu J, et al
    The effect of light therapy on sleep disorders and psychobehavioral symptoms in patients with Alzheimer's disease: A meta-analysis.
    PLoS One. 2023;18:e0293977.
    >> Share


  247. Expression of Concern: Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer's Diseases.
    PLoS One. 2023;18:e0295638.
    >> Share

  248. TANKSLEY PT, Logan MW, Barnes JC
    History of incarceration and age-related neurodegeneration: Testing models of genetic and environmental risks in a longitudinal panel study of older adults.
    PLoS One. 2023;18:e0288303.
    >> Share

  249. ZHOU Q, Xiong Z, Yang D, Xiong C, et al
    The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295135.
    >> Share

  250. WANG E, Hagberg O, Malmstrom PU
    The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.-A Swedish nationwide cohort study from 1997 to 2019.
    PLoS One. 2023;18:e0292174.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016